When a decision is made to prescribe a topical beta-blocker for monotherapy or as an add-on agent, timolol hemihydrate (Betimol, Santen) offers many advantages that may make it an excellent option.
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children
ROP: Treating and preventing blindness in preterm babies
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia
Managing a changing landscape of IRD pediatric cases
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management
Bipartisan proposal introduced in US House to address children's vision impairment